论文部分内容阅读
目的研究分析静脉药物治疗小儿阵发性室上性心动过速的临床疗效和复律时间,为临床治疗提供依据。方法 90例小儿阵发性室上性心动过速患儿,随机分为A组、B组、C组,各30例。A组患儿给予心律平治疗,B组患儿给予西地兰治疗,C组患儿给予胺碘酮治疗,观察三组患儿的转复率及平均复律时间。结果 A组转复率与B组、C组对比,差异无统计学意义(χ~2=0.32、0.09,P>0.05);B组转复率与C组对比差异无统计学意义(χ~2=0.74,P>0.05)。A组平均复律时间与B组对比,差异有统计学意义(t=31.63,P<0.05);A组平均复律时间与C组对比,差异有统计学意义(t=27.96,P<0.05);B组平均复律时间与C组对比,差异有统计学意义(t=4.92,P<0.05)。结论心律平、西地兰、胺碘酮等抗心律失常药物临床治疗效果相近,但药物的特点及适应证不同,用于治疗小儿阵发性室上性心动过速时,要根据患儿病情选择合适的药物进行治疗,促进复律成功,可临床进一步推广。
Objective To study the clinical efficacy and time of cardioversion in patients with paroxysmal supraventricular tachycardia treated by intravenous drug, so as to provide basis for clinical treatment. Methods 90 cases of children with paroxysmal supraventricular tachycardia were randomly divided into A group, B group, C group, each 30 cases. A group of children given heart rhythm treatment, B group given cedilanid treatment, C group given amiodarone treatment, observation of three groups of children with the recovery rate and the average cardioversion time. Results There was no significant difference in the recovery rate between group A and group B and group C (χ ~ 2 = 0.32, 0.09, P> 0.05). There was no significant difference between group B and group C (χ ~ 2 = 0.74, P> 0.05). The mean duration of cardioversion in group A was significantly higher than that in group B (t = 31.63, P <0.05). The mean duration of cardioversion in group A was significantly higher than that in group C (t = 27.96, P <0.05) ). The mean duration of cardioversion in group B was significantly lower than that in group C (t = 4.92, P <0.05). Conclusions The clinical effects of antiarrhythmic drugs such as ropivacaine, cedilanid and amiodarone are similar, but the characteristics and indications of the drugs are different. For the treatment of paroxysmal supraventricular tachycardia in children, Select the appropriate drug for treatment, to promote successful cardioversion can be further clinical promotion.